493 completed, 42 terminated, 42 unknown, 23 withdrawn. 119 Phase 2, 116 Not applicable, 106 Phase 1, 91 Phase 3, 87 Phase 4.
Follow HIV Infection: new trials by email Literature Review of HIV Infection trials Research Report on HIV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Medical Examination - HIV Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Reaching Persons With HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy - The RELAI Study Field-based LA-CAB/RPV - HIV Infection | Phase 4 | Not yet recruiting | University of North Carolina, Chapel Hill | 40 | 2027-01-01 | 2026-10-26 |
| Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial Best Practice, Health Promotion and Education, HPV Self-Collection - HIV Infection, Human Papillomavirus-Related Cervical Carcinoma | Not applicable | Not yet recruiting | Emory University | 2280 | 2026-12-31 | 2026-09-17 |
| DOR/ISL in Pediatric Participants With HIV-1, <18 Years of Age and ≥ 35 kg DOR/ISL - HIV-1, HIV Infection | Phase 2 | Not yet recruiting | Merck Sharp & Dohme LLC | 45 | 2026-12-23 | 2026-10-07 |
| HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM) Prospective - HIV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 220 | 2026-12-01 | 2026-10-29 | |
| An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection | Phase 3 | Not yet recruiting | University College, London | 800 | 2026-11-01 | 2026-08-28 |
| Expanding HOPE Liver HIV Infection, Liver Transplant | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 2026-10-15 | 2026-08-21 | |
| Baricitinib Curative Repression of HIV-1 Antiretroviral Therapy (ART), Baricitinib (LY3009104) 2 mg, Baricitinib (LY3009104) 4 mg - HIV Infection, HIV | Phase 2 | Not yet recruiting | Emory University | 35 | 2026-10-01 | 2026-08-17 |
| Strengthening, Guidance, Health, Empowerment Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 200 | 2026-09-01 | 2026-08-26 |
| Acceptability, Quality of Care, Patient Satisfaction, and Cost-effectiveness of Monitoring Provided by Nurses or Physicians for People Using HIV Pre-exposure Prophylaxis Monitoring of PrEP by nurses, Monitoring of PrEP by physicians - HIV Infection, Pre Exposure Prophylaxis | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 504 | 2026-09-01 | 2026-08-04 |
| Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy HIV PrEP - choice of F/TDF, F/TAF, or CAB-LA, STI PEP - Doxycycline as Doxy-PEP, 3P mHealth package - HIV Infection, Sexually Transmitted Infection | Phase 3 | Not yet recruiting | HIV Prevention Trials Network | 400 | 2026-09-01 | 2026-06-22 |
| Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III Cohort HIV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 128 | 2026-08-01 | 2026-08-18 | |
| Pilot Study to Evaluate Efficacy and Safety of Switching to BIC/FTC/TAF in PWH With a Previous Virological Failure Under CAB/RPV LAI HIV Infection | Not yet recruiting | Cristina Mussini | 30 | 2026-07-01 | 2026-07-07 | |
| #TranscendentHealth: A Text Messaging Pregnancy Prevention Program for Transgender Boys #TranscendentHealth, Universal Sexual Health Program - Pregnancy (Unwanted), Sexually Transmitted Disease (STD) | Not applicable | Not yet recruiting | Center for Innovative Public Health Research | 467 | 2026-06-30 | 2026-07-02 |
| Colchicine to Reduce Coronary Artery Inflammation in People With HIV Colchicine 0.5 mg, Placebo - HIV Infection, Cardiovascular Diseases (CVD) | Phase 2 | Recruiting | Instituto de Investigación Hospital Universitario La Paz | 90 | 2026-06-01 | 2026-07-15 |
| Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma Oral Antiretroviral Therapy, albuvirtide, Cabotegravir/Rilpivirine - AIDS-related Lymphoma, HIV Infection | Not applicable | Recruiting | Shanghai Public Health Clinical Center | 60 | 2026-05-26 | 2026-07-27 |
| Dental Management of Patients With HIV in Pays de la Loire HIV infection status and clinical characteristics - HIV Infection, Acquired Immune Deficiency Syndrome | Recruiting | Nantes University Hospital | 5603 | 2026-05-02 | 2026-06-25 | |
| Menopausal HT for Women Living With HIV (HoT) Transdermal estradiol gel, Micronized Progesterone, Placebo for estradiol gel - HIV Infection, Menopause | Phase 4 | Recruiting | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 105 | 2026-04-09 | 2026-05-22 |
| "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" Blood sampling, Umbilical cord blood sampling, Survey using a questionnaire - HIV Infection, HBV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 5160 | 2026-02-01 | 2026-02-17 |
Showing 20 of 653. Sign in to see all of them.
HIV Infections (653) · Acquired Immunodeficiency Syndrome (80) · Hepatitis C (22) · Hepatitis B (17) · Infections (17) · Inflammation (16) · Sexually Transmitted Diseases (12) · Anus Neoplasms (10) · Cardiovascular Diseases (10) · Sarcoma, Kaposi (10) · Neoplasms (9) · Tuberculosis (9) · Lymphoma, Non-Hodgkin (8) · Medication Adherence (8) · Substance-Related Disorders (8)
Blood-Borne Infections (653) · Communicable Diseases (653) · Genital Diseases (653) · Urogenital Diseases (653) · Retroviridae Infections (652) · Immune System Diseases (651) · Lentivirus Infections (651) · Sexually Transmitted Diseases, Viral (651) · RNA Virus Infections (650) · Immunologic Deficiency Syndromes (649) · Virus Diseases (649) · Sexually Transmitted Diseases (641) · Infections (636) · Slow Virus Diseases (80) · Pathological Conditions, Signs and Symptoms (79)
Ritonavir (35) · Raltegravir Potassium (31) · efavirenz (27) · Tenofovir (26) · Emtricitabine (20) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (20) · Lamivudine (19) · Lopinavir (16) · Atazanavir Sulfate (15) · abacavir (14) · lopinavir-ritonavir drug combination (13) · Blood Specimen Collection (12) · Maraviroc (12) · Darunavir (10) · abacavir, lamivudine drug combination (10)
National Institute of Allergy and Infectious Diseases (NIAID) (41) · ANRS, Emerging Infectious Diseases (32) · National Cancer Institute (NCI) (24) · University of North Carolina, Chapel Hill (24) · GlaxoSmithKline (21) · AIDS Malignancy Consortium (17) · French National Agency for Research on AIDS and Viral Hepatitis (13) · Merck Sharp & Dohme LLC (12) · University of California, San Francisco (12) · ViiV Healthcare (12) · Boston Medical Center (10) · Harvard School of Public Health (HSPH) (8) · St Stephens Aids Trust (8) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (7) · Fred Hutchinson Cancer Center (7)
United States (296) · France (64) · Spain (59) · Italy (38) · Canada (35) · South Africa (34) · United Kingdom (33) · Puerto Rico (29) · Germany (27) · Brazil (26) · Thailand (24) · Uganda (23) · Switzerland (22) · Australia (20) · Belgium (19)
Jeffrey Samet, MD, MA, MPH (5) · Priscilla Hsue, MD (5) · Marta Boffito, Dr (4) · Connie Celum, MD, MPH (3) · Jonathan Ellen, MD (3) · Ligia Peralta, MD (3)
PMID 31999736, PMID 40190112, PMID 20074791, PMID 21951596, PMID 25904376, PMID 26332605, PMID 26797215, PMID 30260797, PMID 30286737, PMID 31179503, PMID 31303143, PMID 33752634, PMID 35179037, PMID 10655111, PMID 10866231, PMID 11387807, PMID 11807307, PMID 11813503, PMID 11915000, PMID 12097549, PMID 12458308, PMID 12562043, PMID 12791866, PMID 15090796, PMID 15456731, PMID 15802979, PMID 15880120, PMID 15905728, PMID 15937765, PMID 16044019, PMID 16184038, PMID 16267740, PMID 16280696, PMID 16340483, PMID 16816557, PMID 16890832, PMID 16905785, PMID 17051493, PMID 17117023, PMID 17215531, PMID 17314338, PMID 17434849, PMID 17460469, PMID 17617272, PMID 17621237, PMID 17631387, PMID 17686878, PMID 17912348, PMID 17919105, PMID 18008230
U01CA121947 (15), UM1CA121947 (15), 2008 (5), 2014 (5), U01AI068636 (5), 2009 (4), 2019 (4), P30CA015704 (4), U01AI068632 (3), P01CA018029 (2), R01DA013806 (2), R01DA031043 (2), R01DA037768 (2), U01AA020780 (2), U01AA020784 (2)